PharmaVoice 21. Nov. 2025 Pharma faces a critical ‘turning point’ in 2026, years in the making #turning point’ #health landscape
PharmaVoice 19. Nov. 2025 As Madrigal faces MASH rivals, keeping patients is as critical as finding new ones #MASH rivals #faces MASH
PharmaVoice 18. Nov. 2025 Amylin could reign supreme in the next wave of obesity drugs #weight management #critical readouts
PharmaVoice 17. Nov. 2025 Developing a path forward in cancer cachexia #Pfizer scientists #cachexia Pfizer
PharmaVoice 17. Nov. 2025 The next leap in Alzheimer’s R&D is coming, but not around the corner #couple drugs #true paradigm
PharmaVoice 14. Nov. 2025 Is that pharma influencer human or AI? #influencer human #pharma influencer
PharmaVoice 13. Nov. 2025 FDA unveils new regulatory roadmap for bespoke drug therapies #Vinay Prasad #Martin Makary